Revance Therapeutics has used ChatGPT in an effort to convince users to “break up with Botox” for the treatment of frown lines in favor of its rival drug Daxxify.
The campaign launched last Tuesday with a 30-second “breakup song,” as well as two videos featuring women practicing their Botox breakup in the mirror. While Revance’s Daxxify is never mentioned in the jingle or videos, a button at the bottom of the campaign’s website captioned, “Meet your new boo,” links to the drug’s website.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters